A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
NCT07361497
This study is recruiting at 34 US sites in 17 states, according to its ClinicalTrials.gov record last updated .
Summary
A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Non-small Cell Lung Cancer (NSCLC)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Bristol-Myers Squibb
- Last updated on ClinicalTrials.gov
- September 30, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- Southern Cancer Center Pc · Daphne, AL
Colorado · 1
- Intermountain Health Cancer Center Lutheran Hospital · Golden, CO
Delaware · 1
- Medical Oncology Hematology Consultants, PA · Newark, DE
Georgia · 1
- Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital · Marietta, GA
Illinois · 3
- University of Chicago Medical Center · Chicago, IL
- Endeavor Health · Evanston, IL
- Illinois Cancer Care · Peoria, IL
Indiana · 1
- Fort Wayne Medical Oncology and Hematology · Fort Wayne, IN
Kentucky · 1
- University of Kentucky Chandler Medical Center · Lexington, KY
Michigan · 1
- Karmanos Cancer Institute · Detroit, MI
Minnesota · 2
- Minnesota Oncology Hematology · Maple Grove, MN
- Allina Health Cancer Institute - Abbott Northwestern Hospital · Minneapolis, MN
Missouri · 1
- Missouri Cancer Associates · Columbia, MO
New York · 2
- Memorial Sloan Kettering Cancer Center · New York, NY
- Optum Medical Care, PC · Westbury, NY
North Carolina · 1
- Novant Health Pharmacy Oncology Specialists · Winston-Salem, NC
Ohio · 5
- Akron General Medical Center · Akron, OH
- The Christ Hospital · Cincinnati, OH
- Cleveland Clinic · Cleveland, OH
- University Hospitals Cleveland Medical Center · Cleveland, OH
- Cleveland Clinic - Hillcrest Hospital · Mayfield Heights, OH
Oregon · 2
- Oncology Associates Of Oregon, Pc · Eugene, OR
- Northwest Cancer Specialists, P.C. · Happy Valley, OR
Tennessee · 2
- SCRI Oncology Partners · Nashville, TN
- Tennessee Oncology · Nashville, TN
Texas · 7
- Texas Oncology - Amarillo Cancer Center · Amarillo, TX
- Texas Oncology-Austin Central · Austin, TX
- Texas Oncology · Denton, TX
- The Center For Cancer And Blood Disorders · Fort Worth, TX
- The University of Texas-MD Anderson Cancer Center · Houston, TX
- Texas Oncology - San Antonio Medical Center · San Antonio, TX
- Texas Oncology - Northeast Texas · Tyler, TX
Virginia · 2
- Blue Ridge Cancer Care · Christiansburg, VA
- Virginia Oncology Associates · Norfolk, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.